You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team are scheduled to participate in three virtual investor conferences in March. Details are as follows: Cowen 41st Annual Health Care Conference Panel Discussion Title: Ovarian Cancer Date: Tuesday, March 2, 2021 Time: 12:50 p.m. Eastern Time H.C. Wainwright Annual Global Life Sciences Conference Date: Tuesday, March 9 Wednesday, March 10, 2021 Morgan Stanley Virtual Healthcare Corporate Access Day Date: Tuesday, March 16, 2021 The prerecorded H.C. Wainwright presentation will be available on Tuesday, March 9, 2021, at 7:00 a.m. Eastern Time in the Investor section of the Companys website at https://ir.reparerx.com/news-and-events/events. A replay of the webcast will be archived on the Companys website for 30 days. About Repare Therapeutics, Inc. Repare Therapeutics is a leading clinical-state precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Companys pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor currently in Phase 1/2 clinical development, as well as RP-6306, a CCNE1-SL inhibitor and a Pol inhibitor program. For more information, please visit reparerx.com. SNIPRx is a registered trademark of Repare Therapeutics Inc.

Answer: Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation